Glutamate ionotropic receptor NMDA type subunit 2A amino-terminal domain zinc binding site (GluN2A ATD zinc site)

The Glutamate ionotropic receptor NMDA type subunit 2A (GluN2A) amino-terminal domain (ATD) zinc binding site is a critical regulatory locus for NMDA receptor activity in the central nervous system. This site exhibits nanomolar affinity for zinc ions, which function as endogenous, non-competitive inhibitors that modulate the receptor's channel open probability in a voltage-independent manner (Paoletti et al., 2000). Structurally, the ATD of GluN2A forms a clamshell-like structure where zinc binding stabilizes a closed conformation, leading to allosteric inhibition of the ion-conducting pore (Karakas et al., 2009). This modulation is essential for maintaining the balance of excitatory signaling, and its disruption is implicated in various pathologies, including epilepsy-aphasia syndromes and schizophrenia (Yuan et al., 2015). Mutations in the GRIN2A gene that affect this zinc-binding site can lead to gain-of-function or loss-of-function phenotypes, contributing to neurodevelopmental disorders (UniProt P35436). Pharmacologically, this site is a target for developing subunit-selective modulators aimed at treating neuropsychiatric conditions without the side effects associated with broad-spectrum NMDA antagonists. By specifically targeting the GluN2A ATD, researchers hope to achieve precise control over synaptic plasticity and neuroprotection.

Other names

GRIN2A zinc siteNMDAR2A amino-terminal domain zinc siteGluN2A N-terminal domain zinc siteNR2A ATD zinc site

Allosteric inhibition of NMDA receptor channel opening through high-affinity binding to the amino-terminal domain of the GluN2A subunit, which stabilizes the closed state of the clamshell-like domain and reduces channel open probability.